Seth Heldenbrand

960 total citations · 1 hit paper
18 papers, 629 citations indexed

About

Seth Heldenbrand is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Family Practice. According to data from OpenAlex, Seth Heldenbrand has authored 18 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in General Health Professions and 4 papers in Family Practice. Recurrent topics in Seth Heldenbrand's work include Innovations in Medical Education (7 papers), Medication Adherence and Compliance (4 papers) and Medical Education and Admissions (3 papers). Seth Heldenbrand is often cited by papers focused on Innovations in Medical Education (7 papers), Medication Adherence and Compliance (4 papers) and Medical Education and Admissions (3 papers). Seth Heldenbrand collaborates with scholars based in United States. Seth Heldenbrand's co-authors include Paul O. Gubbins, Bradley C. Martin, Lindsey Dayer, Paul N. Anderson, Daniel R. Malcom, Kristie Hadden, Schwanda K. Flowers, Catherine E. O’Brien, Eric M. Tichy and Amy M. Franks and has published in prestigious journals such as Annals of Pharmacotherapy, American Journal of Health-System Pharmacy and JMIR mhealth and uhealth.

In The Last Decade

Seth Heldenbrand

17 papers receiving 606 citations

Hit Papers

Smartphone medication adherence apps: Potential benefits ... 2013 2026 2017 2021 2013 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seth Heldenbrand United States 11 250 199 125 83 77 18 629
Lindsey Dayer United States 8 228 0.9× 193 1.0× 93 0.7× 61 0.7× 29 0.4× 26 492
Kirsten Bobrow United Kingdom 11 305 1.2× 99 0.5× 112 0.9× 21 0.3× 124 1.6× 19 624
Jean‐Venable R. Goode United States 13 183 0.7× 105 0.5× 128 1.0× 313 3.8× 103 1.3× 49 813
Richard Chung United States 17 254 1.0× 155 0.8× 106 0.8× 88 1.1× 118 1.5× 34 728
Bill G. Felkey United States 10 144 0.6× 219 1.1× 57 0.5× 200 2.4× 33 0.4× 72 598
Elaine Lum Singapore 16 296 1.2× 56 0.3× 79 0.6× 88 1.1× 38 0.5× 47 710
Yen‐Ming Huang Taiwan 13 219 0.9× 234 1.2× 29 0.2× 131 1.6× 51 0.7× 45 505
Brenda Brunner-Jackson United States 12 333 1.3× 120 0.6× 144 1.2× 10 0.1× 39 0.5× 15 648
Zhao Ni United States 14 211 0.8× 45 0.2× 61 0.5× 25 0.3× 108 1.4× 57 534
Sajid Mahmood Pakistan 14 211 0.8× 68 0.3× 136 1.1× 43 0.5× 66 0.9× 30 744

Countries citing papers authored by Seth Heldenbrand

Since Specialization
Citations

This map shows the geographic impact of Seth Heldenbrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Heldenbrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Heldenbrand more than expected).

Fields of papers citing papers by Seth Heldenbrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth Heldenbrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Heldenbrand. The network helps show where Seth Heldenbrand may publish in the future.

Co-authorship network of co-authors of Seth Heldenbrand

This figure shows the co-authorship network connecting the top 25 collaborators of Seth Heldenbrand. A scholar is included among the top collaborators of Seth Heldenbrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth Heldenbrand. Seth Heldenbrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Robinson, Jennifer D., Lindsey Dayer, Seth Heldenbrand, & Kimberly C. McKeirnan. (2025). A longitudinal study assessing prevalence of stress in student pharmacists at two programs. Currents in Pharmacy Teaching and Learning. 18(3). 102551–102551.
2.
Dayer, Lindsey & Seth Heldenbrand. (2024). Remediation strategies for student pharmacists with socio‐behavioral issues in the experiential curriculum: A case series. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(12). 1172–1178. 1 indexed citations
3.
Dayer, Lindsey, et al.. (2024). A Multisite, Longitudinal Study Assessing Prevalence of Anxiety in Student Pharmacists. American Journal of Pharmaceutical Education. 88(12). 101334–101334. 1 indexed citations
4.
Heldenbrand, Seth, et al.. (2023). A multisite, longitudinal study assessing prevalence of depression in student pharmacists. American Journal of Pharmaceutical Education. 88(2). 100634–100634. 1 indexed citations
5.
Heldenbrand, Seth, et al.. (2020). A Paradigm Shift in US Experiential Pharmacy Education Accelerated by the COVID-19 Pandemic. American Journal of Pharmaceutical Education. 84(6). ajpe8149–ajpe8149. 56 indexed citations
6.
Culhane, Nicole S, et al.. (2020). A Curriculum Crosswalk of the Core Entrustable Professional Activities for New Pharmacy Graduates. American Journal of Pharmaceutical Education. 84(11). 8077–8077. 12 indexed citations
7.
Flowers, Schwanda K., et al.. (2018). Becoming more holistic: A literature review of nonacademic factors in the admissions process of colleges and schools of pharmacy and other health professions. Currents in Pharmacy Teaching and Learning. 10(10). 1429–1437. 9 indexed citations
8.
Maldonado, Angela Q., Patricia West‐Thielke, Mary Amanda Dew, et al.. (2018). Meeting report: Consensus recommendations for a research agenda to address immunosuppressant nonadherence in organ transplantation. Clinical Transplantation. 32(9). e13362–e13362. 11 indexed citations
9.
Dayer, Lindsey, et al.. (2017). Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points. JMIR mhealth and uhealth. 5(4). e45–e45. 29 indexed citations
10.
Heldenbrand, Seth, Lindsey Dayer, Bradley C. Martin, et al.. (2017). APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA. American Journal of Pharmaceutical Education. 82(7). 6326–6326. 15 indexed citations
11.
Heldenbrand, Seth, Schwanda K. Flowers, Paul O. Gubbins, et al.. (2016). Multiple Mini-Interview Performance Predicts Academic Difficulty in the PharmD Curriculum. American Journal of Pharmaceutical Education. 80(2). 27–27. 24 indexed citations
12.
Maldonado, Angela Q., et al.. (2016). Nonadherence to therapy after adult solid organ transplantation: A focus on risks and mitigation strategies. American Journal of Health-System Pharmacy. 73(12). 909–920. 10 indexed citations
13.
Heldenbrand, Seth, Chenghui Li, Travis B. Dick, et al.. (2016). Multicenter evaluation of efficacy and safety of low‐dose versus high‐dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients. Transplant Infectious Disease. 18(6). 904–912. 27 indexed citations
15.
Syal, Gaurav, Seth Heldenbrand, & Andrés Duarte‐Rojo. (2014). Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir. American Journal of Therapeutics. 23(2). e570–e571. 2 indexed citations
16.
Dayer, Lindsey, Seth Heldenbrand, Paul N. Anderson, Paul O. Gubbins, & Bradley C. Martin. (2013). Smartphone medication adherence apps: Potential benefits to patients and providers. Journal of the American Pharmacists Association. 53(2). 172–181. 334 indexed citations breakdown →
17.
Gubbins, Paul O. & Seth Heldenbrand. (2009). Clinically relevant drug interactions of current antifungal agents. Mycoses. 53(2). 95–113. 52 indexed citations
18.
Warmack, T. Scott, Mark Estes, Seth Heldenbrand, & Amy M. Franks. (2009). β-Adrenergic Antagonists in Hypertension: A Review of the Evidence. Annals of Pharmacotherapy. 43(12). 2031–2043. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026